pcdna3 cdk8 ha (Addgene inc)
Structured Review

Pcdna3 Cdk8 Ha, supplied by Addgene inc, used in various techniques. Bioz Stars score: 91/100, based on 2 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/pcdna3+cdk8+ha/pcDNA3+CDK8+HA+(P%23634)+(Plasmid+%2314649)/pmc11705631-44-10-19
Average 91 stars, based on 2 article reviews
Images
1) Product Images from "The Cyclin-Dependent Kinase 8 Inhibitor E966-0530-45418 Attenuates Pulmonary Fibrosis In Vitro and In Vivo"
Article Title: The Cyclin-Dependent Kinase 8 Inhibitor E966-0530-45418 Attenuates Pulmonary Fibrosis In Vitro and In Vivo
Journal: International Journal of Biological Sciences
doi: 10.7150/ijbs.105826
Figure Legend Snippet: E966-0530-45418 inhibited the activation of EMT and the collagen I protein in TGFβ1-evoked human primary AECs. ( A - F ) Human primary AECs were transfected with the pcDNA3 CDK8-HA plasmid (1 μg) for 24 h, treated with E966-0530-45418 (5 μM), pirfenidone (1 mM) or not for 1 h, and then incubated with TGFβ1 (10 ng/mL) for an additional 24 h (A-D) or 3 h (E and F). Immunofluorescence analysis using a high-content imaging system (ImageXpress Micro confocal microscope) was used to evaluate E-cadherin and CDK8 protein expression. Images were taken at 200 × magnification (Scale bar: 50 μm) (n = 5 independent samples per group) (A and B). The protein levels of COL1A1 and CDK8 were determined by western blotting (n = 5 independent samples per group) (C and D). The protein levels of p-Smad3 T179 and CDK8 were assessed by flow cytometry (n = 6 independent samples per group) (E and F). The results are shown as the mean ± SEM. P values were determined using one-way ANOVA followed by Tukey's post hoc test (B, D, and F).
Techniques Used: Activation Assay, Transfection, Plasmid Preparation, Incubation, Immunofluorescence, Imaging, Microscopy, Expressing, Western Blot, Flow Cytometry
Related Articles
Recombinant:Article Title: The Cyclin-Dependent Kinase 8 Inhibitor E966-0530-45418 Attenuates Pulmonary Fibrosis In Vitro and In Vivo Article Snippet: The primary antibody against Pin 1 (sc-46660) was obtained from Santa Cruz Biotechnology (Dallas, Texas, USA). .. Recombinant human TGFβ1 was obtained from PeproTech (Cranbury, NJ, USA). Plasmid Preparation:Article Title: The Cyclin-Dependent Kinase 8 Inhibitor E966-0530-45418 Attenuates Pulmonary Fibrosis In Vitro and In Vivo Article Snippet: The primary antibody against Pin 1 (sc-46660) was obtained from Santa Cruz Biotechnology (Dallas, Texas, USA). .. Recombinant human TGFβ1 was obtained from PeproTech (Cranbury, NJ, USA). Article Title: The study of a novel CDK8 inhibitor E966-0530-45418 that inhibits prostate cancer metastasis in vitro and in vivo. Article Snippet: Prostate cancer is a prevalent malignancy among men globally, and androgen deprivation therapy is the conventional first-line treatment for metastatic prostate cancer.. While androgen deprivation therapy is efficacious in castration-sensitive prostate cancer, it remains less effective in castration-resistant cases.. Transcriptional dysregulation is a well-established hallmark of cancer, and targeting proteins involved in transcriptional regulation, such as cyclin-dependent kinase 8 (CDK8), has become an attractive therapeutic strategy. Retroviral:Article Title: Cyclin C is a haploinsufficient tumor suppressor Article Snippet: .. HA-FBW7, shFBW7 lentiviral vectors were described previously 62 . Article Title: Cyclin C is a haploinsufficient tumor suppressor Article Snippet: .. Plasmids HA-FBW7, shFBW7 lentiviral vectors were described previously 62 . |

